KSHV infection and the pathogenesis of Kaposi's sarcoma.

Kaposi's sarcoma (KS) has long been suspected of having an infectious etiology on the basis of its unusual epidemiology, histopathology, and natural history. Nearly a decade ago, a novel herpesviral genome was discovered in KS biopsies, and since that time strong epidemiologic evidence has accumulated correlating infection with this KS-associated herpesvirus (KSHV, also known as human herpesvirus 8) with the development of the disease. Here we review the evidence linking KSHV infection to KS risk and discuss current notions of how KSHV gene expression promotes the development of this remarkable neoplasm. These studies show that both latent and lytic viral replicative cycles contribute significantly-but differently-to KS development. The studies also highlight mechanistic differences between oncogenesis caused by KSHV and that caused by its distant relative Epstein-Barr virus.

[1]  Frederick Y. Wu,et al.  A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma–associated herpesvirus latency , 2003, Nature Medicine.

[2]  D. Ganem,et al.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. , 2004, The Journal of clinical investigation.

[3]  C. Boshoff,et al.  Cyclin encoded by KS herpesvirus , 1996, Nature.

[4]  S. Korsmeyer,et al.  The apoptotic v-cyclin–CDK6 complex phosphorylates and inactivates Bcl-2 , 2000, Nature Cell Biology.

[5]  S. Howell,et al.  KSHV vFLIP binds to IKK-γ to activate IKK , 2003, Journal of Cell Science.

[6]  C. Boshoff,et al.  Degradation of p27Kip cdk inhibitor triggered by Kaposi's sarcoma virus cyclin–cdk6 complex , 1999, The EMBO journal.

[7]  T. Schulz,et al.  Latent Nuclear Antigen of Kaposi’s Sarcoma-Associated Herpesvirus Interacts with RING3, a Homolog of theDrosophila Female Sterile Homeotic (fsh) Gene , 1999, Journal of Virology.

[8]  A. Krithivas,et al.  Human Herpesvirus 8 LANA Interacts with Proteins of the mSin3 Corepressor Complex and Negatively Regulates Epstein-Barr Virus Gene Expression in Dually Infected PEL Cells , 2000, Journal of Virology.

[9]  T. Piolot,et al.  Close but Distinct Regions of Human Herpesvirus 8 Latency-Associated Nuclear Antigen 1 Are Responsible for Nuclear Targeting and Binding to Human Mitotic Chromosomes , 2001, Journal of Virology.

[10]  Frederick Y. Wu,et al.  Spindle Cell Conversion by Kaposi's Sarcoma-Associated Herpesvirus: Formation of Colonies and Plaques with Mixed Lytic and Latent Gene Expression in Infected Primary Dermal Microvascular Endothelial Cell Cultures , 2001, Journal of Virology.

[11]  C. Lim,et al.  Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus Functionally Interacts with Heterochromatin Protein 1* , 2003, The Journal of Biological Chemistry.

[12]  B. Chandran,et al.  Activation of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Lytic Replication by Human Cytomegalovirus , 2001, Journal of Virology.

[13]  E. Cesarman,et al.  Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation , 1997, Nature.

[14]  E. Operskalski,et al.  The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.

[15]  Tong-Yuan Yang,et al.  Transgenic Expression of the Chemokine Receptor Encoded by Human Herpesvirus 8 Induces an Angioproliferative Disease Resembling Kaposi's Sarcoma , 2000, The Journal of experimental medicine.

[16]  L. Gradoville,et al.  Open Reading Frame 50 Protein of Kaposi's Sarcoma-Associated Herpesvirus Directly Activates the Viral PAN and K12 Genes by Binding to Related Response Elements , 2002, Journal of Virology.

[17]  D. Ganem,et al.  The Kaposin B Protein of KSHV Activates the p38/MK2 Pathway and Stabilizes Cytokine mRNAs , 2005, Science.

[18]  P. Volberding Kaposi's sarcoma in AIDS. , 1989, Immunology series.

[19]  D. Ganem,et al.  The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Permits Replication of Terminal Repeat-Containing Plasmids , 2003, Journal of Virology.

[20]  Shou-Jiang Gao,et al.  Productive Lytic Replication of a Recombinant Kaposi's Sarcoma-Associated Herpesvirus in Efficient Primary Infection of Primary Human Endothelial Cells , 2003, Journal of Virology.

[21]  M. Tremblay,et al.  Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation. , 2001, Journal of human virology.

[22]  E. Jaffe,et al.  Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. , 1999, Blood.

[23]  Shou-Jiang Gao,et al.  Efficient Infection by a Recombinant Kaposi's Sarcoma-Associated Herpesvirus Cloned in a Bacterial Artificial Chromosome: Application for Genetic Analysis , 2002, Journal of Virology.

[24]  D. Ganem,et al.  Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells , 2003, Journal of Virology.

[25]  M. Eby,et al.  The Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein Physically Associates with and Persistently Activates the IκB Kinase Complex* , 2002, The Journal of Biological Chemistry.

[26]  G. Wood,et al.  Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. , 1985, The American journal of pathology.

[27]  T. Schulz,et al.  Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. , 1999, Advances in cancer research.

[28]  M. Skobe,et al.  Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. , 1999, The Journal of investigative dermatology.

[29]  D. Ganem,et al.  Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. , 2004, Molecular cell.

[30]  S. Henderson,et al.  Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma , 2004, Nature Genetics.

[31]  E. van Marck,et al.  Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Regezi,et al.  Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells. , 1993, The American journal of pathology.

[33]  P. Moore,et al.  Viral IL-6-Induced Cell Proliferation and Immune Evasion of Interferon Activity , 2002, Science.

[34]  G. Hayward,et al.  Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6 , 1997, Nature Medicine.

[35]  M. Mildner,et al.  Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[36]  E. Robertson,et al.  The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. , 1999, Virology.

[37]  J. Nicholas Human herpesvirus-8-encoded signalling ligands and receptors. , 2003, Journal of biomedical science.

[38]  B. Gazzard,et al.  A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma , 2003, AIDS.

[39]  M. Gaestel,et al.  Is MK2 (mitogen-activated protein kinase-activated protein kinase 2) the key for understanding post-transcriptional regulation of gene expression? , 2001, Biochemical Society transactions.

[40]  J. Gutkind,et al.  The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. , 2000, Cancer research.

[41]  S. Mittnacht,et al.  p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma , 2002, Oncogene.

[42]  R. Sun,et al.  Comparative Study of Regulation of RTA-Responsive Genes in Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 , 2003, Journal of Virology.

[43]  P. Murphy,et al.  Kaposi’s Sarcoma-Associated Herpesvirus G Protein-Coupled Receptor Constitutively Activates NF-κB and Induces Proinflammatory Cytokine and Chemokine Production Via a C-Terminal Signaling Determinant , 2001, The Journal of Immunology.

[44]  N. Bendsøe,et al.  Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. , 1996, The American journal of pathology.

[45]  M. McGrath,et al.  Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.

[46]  D. Hanahan,et al.  Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. , 1996, European journal of cancer.

[47]  M. Ballestas,et al.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mediates Episome Persistence through cis-Acting Terminal Repeat (TR) Sequence and Specifically Binds TR DNA , 2001, Journal of Virology.

[48]  L. Hood,et al.  Modulation of the NF-κB pathway by virally encoded Death Effector Domains-containing proteins , 1999, Oncogene.

[49]  Ren Sun,et al.  Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta. , 2002, Virology.

[50]  B. Nathwani,et al.  Evidence for multiclonality in multicentric Kaposi's sarcoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  B. Haar,et al.  Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8 , 1997, Journal of virology.

[52]  R. Schooley,et al.  Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage , 2000, AIDS.

[53]  J. Derisi,et al.  Modulation of host gene expression by the constitutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus. , 2002, Cancer research.

[54]  P. Moore,et al.  Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53 , 2001, Journal of Virology.

[55]  J. Gutkind,et al.  Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. , 2003, Cancer cell.

[56]  S. Mori,et al.  Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. , 2000, Virology.

[57]  C. Atzler,et al.  Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1. , 2001, Molecular cell.

[58]  D. Dittmer,et al.  Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. , 2000, Virology.

[59]  L. Szekely,et al.  A Domain in the C-Terminal Region of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Affects Transcriptional Activation and Binding to Nuclear Heterochromatin , 2003, Journal of Virology.

[60]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[61]  P. Monini,et al.  Biology of Kaposi's sarcoma. , 2001, European journal of cancer.

[62]  L. Liotta,et al.  Monoclonal origin of multicentric Kaposi's sarcoma lesions. , 1997, The New England journal of medicine.

[63]  R. Leurs,et al.  Kaposi's Sarcoma-Associated Herpesvirus-Encoded G Protein-Coupled Receptor ORF74 Constitutively Activates p44/p42 MAPK and Akt via Gi and Phospholipase C-Dependent Signaling Pathways , 2002, Journal of Virology.

[64]  J. Regezi,et al.  Oral Kaposi's sarcoma: a 10-year retrospective histopathologic study. , 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[65]  Lijun Wu,et al.  A Complex Translational Program Generates Multiple Novel Proteins from the Latently Expressed Kaposin (K12) Locus of Kaposi’s Sarcoma-Associated Herpesvirus , 1999, Journal of Virology.

[66]  P. Brown,et al.  Modulation of Cellular and Viral Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.

[67]  J. Brady,et al.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells , 2003, Journal of Virology.

[68]  J. Tschopp,et al.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.

[69]  Jianhong Hu,et al.  DNA Binding and Modulation of Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.

[70]  J. Goedert,et al.  Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma , 2003, AIDS.

[71]  A. Srinivasan,et al.  Human herpesvirus-8 encoded Kaposin: subcellular localization using immunofluorescence and biochemical approaches. , 2002, DNA and cell biology.

[72]  E. Tschachler,et al.  Kaposi's Sarcoma-Like Tumors in a Human Herpesvirus 8 ORF74 Transgenic Mouse , 2003, Journal of Virology.

[73]  N. Jones,et al.  Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins , 1997, Nature.

[74]  P. Stewart,et al.  Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. , 2002, The Journal of infectious diseases.

[75]  C. Boshoff,et al.  Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma , 1995, The Lancet.

[76]  A. Haase,et al.  A Cluster of Latently Expressed Genes in Kaposi’s Sarcoma-Associated Herpesvirus , 1998, Journal of Virology.

[77]  P. Moore,et al.  Characterization and Cell Cycle Regulation of the Major Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Latent Genes and Their Promoter , 1999, Journal of Virology.

[78]  C. Boshoff,et al.  The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma–E2F pathway and with the oncogene Hras transforms primary rat cells , 2000, Nature Medicine.

[79]  Jianhong Hu,et al.  Latency-associated Nuclear Antigen (LANA) Cooperatively Binds to Two Sites within the Terminal Repeat, and Both Sites Contribute to the Ability of LANA to Suppress Transcription and to Facilitate DNA Replication* , 2002, The Journal of Biological Chemistry.

[80]  W. Hammerschmidt,et al.  Spontaneous Activation of the Lytic Cycle in Cells Infected with a Recombinant Kaposi's Sarcoma-Associated Virus , 2001, Journal of Virology.

[81]  P. Biberfeld,et al.  The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors , 1999, The Journal of experimental medicine.

[82]  C. Lim,et al.  Functional Dissection of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Involved in Latent DNA Replication and Transcription of Terminal Repeats of the Viral Genome , 2002, Journal of Virology.

[83]  É. Oksenhendler,et al.  Molecular analysis of clonality in Kaposi's sarcoma. , 1997, Journal of clinical pathology.

[84]  Kaposi,et al.  Idiopathisches multiples Pigmentsarkom der Haut , 1872, Archiv für Dermatologie und Syphilis.

[85]  P. Pellett,et al.  Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus , 2003, AIDS.

[86]  M. Dahiya,et al.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces Expression of the Helix-Loop-Helix Protein Id-1 in Human Endothelial Cells , 2003, Journal of Virology.

[87]  R. Gallo,et al.  Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[88]  R. Sun,et al.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[89]  J. Brady,et al.  Identification of Kaposin (Open Reading Frame K12) as a Human Herpesvirus 8 (Kaposi’s Sarcoma-Associated Herpesvirus) Transforming Gene , 1998, Journal of Virology.

[90]  M. Corbellino,et al.  Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. , 2000, The American journal of pathology.

[91]  M. McMahon,et al.  De Novo Infection and Serial Transmission of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Endothelial Cells , 2002, Journal of Virology.

[92]  M. Kaplan,et al.  Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma , 1995, The Lancet.

[93]  E. Cesarman,et al.  G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.

[94]  P. Moore,et al.  Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.

[95]  P. Allavena,et al.  The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. , 1998, Blood.

[96]  A. Haase,et al.  Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells , 1997, Journal of virology.

[97]  Jianhong Hu,et al.  The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Supports Latent DNA Replication in Dividing Cells , 2002, Journal of Virology.

[98]  D. Noonan,et al.  KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma. , 1996, Research in virology.

[99]  E. Cesarman,et al.  Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. , 2000, Blood.

[100]  D. Ganem,et al.  Highly Selective Escape from KSHV-mediated Host mRNA Shutoff and Its Implications for Viral Pathogenesis , 2004, The Journal of experimental medicine.

[101]  E. Geras-Raaka,et al.  Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. , 1998, The Journal of clinical investigation.

[102]  M. Ballestas,et al.  Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. , 1999, Science.

[103]  T. Veikkola,et al.  Vascular Endothelial Growth Factor-C Stimulates the Migration and Proliferation of Kaposi’s Sarcoma Cells* , 1999, The Journal of Biological Chemistry.

[104]  N. Jones,et al.  The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. , 2002, Cancer cell.

[105]  J. Phair,et al.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.

[106]  D. Ganem,et al.  Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. , 1998, Virology.

[107]  C. Boshoff,et al.  Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.

[108]  G. Nabel,et al.  p53 inhibition by the LANA protein of KSHV protects against cell death , 1999, Nature.

[109]  T. Veikkola,et al.  Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6. , 1999, Cancer research.

[110]  C. Boshoff,et al.  The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1 , 1997, Journal of virology.

[111]  E. Tschachler,et al.  Expression of HHV‐8 latency‐associated T0.7 RNA in spindle cells and endothelial cells of AIDS‐associated, classical and African Kaposi's sarcoma , 1997, International journal of cancer.

[112]  C. Cockerell Histopathological features of Kaposi's sarcoma in HIV infected individuals. , 1991, Cancer surveys.

[113]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma , 1996, Journal of virology.

[114]  L. Szekely,et al.  Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions. , 2002, The Journal of general virology.

[115]  S. Rafii,et al.  Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus , 1998, Nature.

[116]  L. Kaplan,et al.  AIDS malignancies in the era of highly active antiretroviral therapy. , 2002, Oncology.

[117]  F. Neipel,et al.  Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin , 1997, Journal of virology.

[118]  F. Neipel,et al.  Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? , 1997, Journal of virology.

[119]  S. Mahajan,et al.  Carboxy Terminus of Human Herpesvirus 8 Latency-Associated Nuclear Antigen Mediates Dimerization, Transcriptional Repression, and Targeting to Nuclear Bodies , 2000, Journal of Virology.

[120]  Jay W. Shin,et al.  Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus , 2004, Nature Genetics.

[121]  M. Stürzl,et al.  Kaposi's sarcoma: a review of gene expression and ultrastructure of KS spindle cells in vivo. , 1992, AIDS research and human retroviruses.

[122]  G. Hayward,et al.  Patterns of Gene Expression and a Transactivation Function Exhibited by the vGCR (ORF74) Chemokine Receptor Protein of Kaposi's Sarcoma-Associated Herpesvirus , 2002, Journal of Virology.

[123]  W. Zhong,et al.  Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[124]  R. Sun,et al.  Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-κB and JNK/AP1 pathways , 2003, Oncogene.

[125]  V. Beral,et al.  Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? , 1990, The Lancet.

[126]  G. Shaw,et al.  A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.

[127]  C. Boshoff,et al.  Internal Ribosome Entry Site Regulates Translation of Kaposi's Sarcoma-Associated Herpesvirus FLICE Inhibitory Protein , 2001, Journal of Virology.

[128]  B. Ensoli,et al.  Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. , 1998, Cytokine & growth factor reviews.

[129]  J. Russo,et al.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[130]  S. Nakamura,et al.  AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. , 1989, Science.

[131]  G. Barillari,et al.  Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma , 2002, Clinical Microbiology Reviews.

[132]  D. Ganem,et al.  The biology of Kaposi's sarcoma. , 2001, Cancer treatment and research.

[133]  L. Bieleski,et al.  Kaposi's Sarcoma-Associated Herpesvirus vCyclin Open Reading Frame Contains an Internal Ribosome Entry Site , 2001, Journal of Virology.

[134]  C. Boshoff,et al.  Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells , 1995, Nature Medicine.

[135]  J. Fallon,et al.  The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium. , 2001, Blood.

[136]  L. Chieco‐Bianchi,et al.  Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. , 2000, Journal of the National Cancer Institute. Monographs.

[137]  S. Nakamura,et al.  Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. , 1988, Science.

[138]  D. Ganem,et al.  Mechanisms Governing Expression of the v-FLIP Gene of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.

[139]  J. Harrington,et al.  Repetitive strain injuries , 1997, The Lancet.

[140]  P. Browning,et al.  Human Immunodeficiency Virus Replication in a Primary Effusion Lymphoma Cell Line Stimulates Lytic-Phase Replication of Kaposi’s Sarcoma-Associated Herpesvirus , 1999, Journal of Virology.

[141]  A. Haase,et al.  Expression of the Open Reading Frame 74 (G-Protein-Coupled Receptor) Gene of Kaposi’s Sarcoma (KS)-Associated Herpesvirus: Implications for KS Pathogenesis , 1999, Journal of Virology.

[142]  Chin‐Yun Lee,et al.  Reciprocal Regulatory Interaction between Human Herpesvirus 8 and Human Immunodeficiency Virus Type 1* , 2001, The Journal of Biological Chemistry.

[143]  C. Boshoff,et al.  KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. , 2000, Blood.

[144]  B. Gazzard,et al.  Prospective Study of the Effects of Antiretroviral Therapy on Kaposi Sarcoma‐Associated Herpesvirus Infection in Patients With and Without Kaposi Sarcoma , 2002, Journal of acquired immune deficiency syndromes.

[145]  C. Pellet,et al.  Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV‐related Kaposi's sarcoma , 1998, AIDS.

[146]  C. Buchrieser,et al.  Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. , 2000, Journal of the National Cancer Institute.

[147]  N. Jones,et al.  Modulation of p27Kip1 levels by the cyclin encoded by Kaposi's sarcoma‐associated herpesvirus , 1999 .

[148]  A. Palestine,et al.  Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. , 1999, The New England journal of medicine.

[149]  T. Hirano,et al.  AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[150]  J. Goedert,et al.  Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors , 2003, Transfusion.

[151]  R. Gray,et al.  Adjuvant therapy for very young women with breast cancer: need for tailored treatments. , 2001, Journal of the National Cancer Institute. Monographs.

[152]  M. Murphey-Corb,et al.  Rhesus rhadinovirus infection in healthy and SIV‐infected macaques at Tulane National Primate Research Center , 2003, Journal of medical primatology.

[153]  C. Lim,et al.  Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. , 2000, The Journal of general virology.

[154]  D R Hoover,et al.  Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma , 1996, AIDS.

[155]  Jeffrey N. Martin,et al.  Sexual transmission and the natural history of human herpesvirus 8 infection. , 1998, The New England journal of medicine.

[156]  R. Sun,et al.  NF-κB Inhibits Gammaherpesvirus Lytic Replication , 2003, Journal of Virology.

[157]  C. Wood,et al.  Activation of HHV-8 by HIV-1 tat , 1997, The Lancet.

[158]  M. Fujimuro,et al.  Protein Interactions Targeting the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus to Cell Chromosomes , 2002, Journal of Virology.